• IPO7 Antibody Market Overview
    The IPO7 Antibody Market was valued at USD 900 million in 2024 and is projected to reach USD 2.5 billion by 2035, growing at a CAGR of 9.3%. IPO7 antibodies target the Importin-7 protein, which plays a critical role in nuclear transport and viral infection pathways, making them valuable for both therapeutic and diagnostic applications. The market is segmented by type into monoclonal antibodies,...
    0 Comments 0 Shares 6 Views 0 Reviews